Results 281 to 290 of about 8,916,335 (397)

State-level LGBTQ+ policies and health: the role of political determinants in shaping health equity [PDF]

Ellesse-Roselee Akré, Nicole Rapfogel, Gabe H. Miller   +2 more
openalex   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Uncovering Mental Health Profiles of Workers with a Physically Disabling Injury or Illness Using the Complete State Mental Health Framework. [PDF]

J Occup Rehabil
Dobson KG, Chien YC, Carnide N, Furlan AD, Smith PM, Mustard CA.   +5 more
europepmc   +1 more source

ICD Use and Clinical Coding Skills Among Health Information Management Professionals: A Case Study of Specialist Hospital Sokoto State

Hamza, A., Sauwa, S. H., Orimoloye, K.
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

US State Public Health Agencies' Use of Twitter From 2012 to 2022: Observational Study.

J Med Internet Res
Mendez SR, Munoz-Najar S, Emmons KM, Viswanath K.   +3 more
europepmc   +1 more source

Low-cost IoT-Based sensors dashboard for monitoring the state of health of mobile harbor cranes: Hardware and software description. [PDF]

Heliyon
Awad AH, Alsabaan M, Ibrahem MI, Saraya MS, Elksasy MSM, Ali-Eldin AMT, Abdelsalam MM.   +6 more
europepmc   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Correction to: The state of health information organizations and plans to participate in the federal exchange framework. [PDF]

Health Aff Sch
europepmc   +1 more source

Protocol: A mixed-methods study to evaluate implementation and outcomes of U.S. state telemental health policy expansion during the COVID-19 pandemic. [PDF]

PLoS One
Leung LB, Santos JJ, Escarce JJ, Ettner SL, Der-Martirosian C, Raja P, McCourt AD, Fortney J, McGinty EE.   +8 more
europepmc   +1 more source